Ravi Shukla
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Materials Chemistry top 1%
- Nanoparticles: synthesis and applications
- Advanced Nanomaterials in Catalysis
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 16
-
- Nanoparticles: synthesis and applications 21
- Advanced Nanomaterials in Catalysis 13
- Co-authors
- Vipul BansalRamesh BhondeMurali SastryMinakshi ChaudharyAtanu BasuRaghuraman KannanNripen ChandaGary Bryant
- Journals
- Molecular Pharmaceutics (5 papers)ACS Applied Bio Materials (3 papers)Asian Journal of Pharmaceutics (3 papers)ACS Omega (3 papers)Pharmaceutical Research (3 papers)
- Partner nations
- AustraliaIndiaUnited States
In The Last Decade
Ravi Shukla
148 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Biomaterials 1.5k
- Materials Chemistry 2.9k
- Electronic, Optical and Magnetic Materials 1.1k
- Biomedical Engineering 2.0k
- Molecular Biology 2.4k
Countries citing papers authored by Ravi Shukla
This map shows the geographic impact of Ravi Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Shukla more than expected).
Fields of papers citing papers by Ravi Shukla
This network shows the impact of papers produced by Ravi Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Shukla. The network helps show where Ravi Shukla may publish in the future.
Co-authors
The 25 scholars most cited alongside Ravi Shukla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 28 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 4 | |
| 8 | 2020 | 62 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 47 | |
| 11 | 2019 | 29 | |
| 12 | 2018 | 27 | |
| 13 | 2016 | 42 | |
| 14 | 2016 | 61 | |
| 15 | 2013 | 4 | |
| 16 | 2011 | 76 | |
| 17 | 2008 | 4 | |
| 18 | 2008 | 14 | |
| 19 | 2008 | 4 | |
| 20 | Survey of neonatal hepatitis B vaccination in Leicestershire. | 1999 | 5 |
About Ravi Shukla
Ravi Shukla is a scholar working on Biomaterials, Materials Chemistry, Biomedical Engineering, Molecular Biology and Library and Information Sciences, having authored 153 papers that have together received 7.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (23 papers), Nanoparticles: synthesis and applications (21 papers), Advanced biosensing and bioanalysis techniques (17 papers), Nanoparticle-Based Drug Delivery (16 papers), Advanced Nanomaterials in Catalysis (13 papers), Gold and Silver Nanoparticles Synthesis and Applications (11 papers), Vehicular Ad Hoc Networks (VANETs) (11 papers) and Mobile Ad Hoc Networks (10 papers). The work is most often cited by research in Biomaterials (1.5k citations), Materials Chemistry (2.9k citations), Electronic, Optical and Magnetic Materials (1.1k citations), Biomedical Engineering (2.0k citations) and Molecular Biology (2.4k citations). Ravi Shukla has collaborated with scholars based in Australia, India and United States. Frequent co-authors include Vipul Bansal, Ramesh Bhonde, Murali Sastry, Minakshi Chaudhary, Atanu Basu, Raghuraman Kannan, Nripen Chanda, Gary Bryant, Kattesh V. Katti and Kavita Katti. Their work appears in journals such as Molecular Pharmaceutics, ACS Applied Bio Materials, Asian Journal of Pharmaceutics, ACS Omega and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.